CADTH.ca

Begin main content

Want to browse reports and resources on high-interest topics? Visit our Evidence Bundles.

Featured Reports

Utilization of Innovator Biologics and Biosimilars for Chronic Inflammatory Diseases in Canada: A Provincial Perspective

Last updated: January 21, 2020

Internet-Based Cognitive Behavioural Therapy for Post-Traumatic Stress Disorder

Last updated: January 20, 2020

Keytruda for Squamous NSCLC – Details

Last updated: January 20, 2020

View all Reports

Upcoming Events

CADTH Lecture — Cost-Effectiveness of Naloxone Kits in Canadian High Schools and Community Centre Settings

Lecture Description The opioid crisis continues to devastate families and communities across Canada. According to the Public Health Agen...

Event Date: March 5, 2020

Non-Pharmacological Interventions for Chronic Non-Cancer Pain: Acupuncture

Because of the prevalence and burden of chronic pain, and the associated opioid crisis in our country, health professionals are looking f...

Event Date: March 16, 2020

2020 CADTH Symposium

Join us in Toronto for the 2020 CADTH Symposium. Connect with Canadian and international experts in the objective assessment and evaluat...

Event Date: April 18, 2020 - April 21, 2020

View all Events

News Feed

Drug Reimbursement Recommendation - tafamidis (Vyndaqel)

Today, CADTH has issued final recommendations for: tafamidis (Vyndaqel) Indications: transthyretin-mediated amyloidosis Recommendatio...

Published on: February 21, 2020

Call for Feedback: Rituximab to Treat Primary Membranous Nephropathy

A new project on Rituximab to Treat Primary Membranous Nephropathy is now available for feedback from all interested stakeholders. Ritux...

Published on: February 13, 2020

New at CADTH — February 2020

Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news ...

Published on: February 10, 2020

View all News